Preclinical and clinical development of deferitrin, a novel, orally available iron chelator.
Ann N Y Acad Sci
; 1054: 492-4, 2005.
Article
en En
| MEDLINE
| ID: mdl-16339704
ABSTRACT
Deferitrin, a novel, orally available iron chelator, is in the early stage of clinical development for the treatment of chronic iron overload due to transfusional therapy. Preclinical pharmacology studies demonstrate iron excretion largely by the fecal route. Initial clinical studies have shown deferitrin to be well absorbed. Further clinical studies are ongoing to determine the efficiency and safety of deferitrin.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Tiazoles
/
Ácidos Carboxílicos
/
Terapia por Quelación
/
Quelantes del Hierro
/
Talasemia beta
/
Sobrecarga de Hierro
Tipo de estudio:
Etiology_studies
Límite:
Animals
/
Humans
Idioma:
En
Año:
2005
Tipo del documento:
Article